Title: Principal
Company: Todd Barker Consulting LLC
Location: Stockton, California, United States
Todd Barker, principal at Todd Barker Consulting LLC, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in chemistry and engineering.
With over three decades of experience to his credit, Dr. Todd Barker has excelled as a leader and innovator in the fields of analytical chemistry, medical devices, and quality engineering. He began his career as a programmer at Abbot Diagnostics from 1991 to 1994. He then moved on to roles at Baxter International from 1994 to 1998 and Roche from 1999 to 2009.
From 2009 to 2013, Dr. Barker served as a senior manager at Ventana Medical Systems, a division of Roche Tissue Diagnostics, before transitioning to managerial positions at F. Hoffmann-La Roche Ltd, where he served as manager of design quality engineering from 2013 to 2016, and subsequently as senior manager from 2016 to 2019. His tenure at F. Hoffmann-La Roche Ltd culminated in his role as senior manager from 2019 to 2020. Prior to founding Todd Barker Consulting LLC in 2023, Dr. Barker was the Apple Health Quality Lead at Apple from 2020 to 2023.
Throughout his career, Dr. Barker has demonstrated a commitment to academic excellence, culminating in his acquisition of a PhD in analytical chemistry from the University of Delaware. Beyond his professional responsibilities, he has been involved in many civic organizations. He is active in the Boy Scouts of America and Toastmasters and has made significant contributions to the field through his written works.
Throughout Dr. Barker’s illustrious career, one highlight stands out prominently: his groundbreaking contribution to medical research through the development of the PCR platform for nucleic acid detection. This innovation revolutionized disease detection, enabling the identification of HIV, hepatitis viruses, and West Nile virus in donated blood samples. The platform’s widespread adoption, achieving nearly 100% market penetration in HIV hotspots like Thailand and utilization in blood banks across the U.S. and various countries, underscores its global impact. His pioneering work played a pivotal role in reducing HIV transmission rates to manageable levels, saving countless lives, and advancing public health efforts worldwide.
Looking ahead, Dr. Barker envisions further growth and development for his company. With a strategic focus on expanding his team and contributions from his family members, all of whom possess technical backgrounds, he hopes to leverage their expertise to enhance the company’s capabilities in areas such as regulatory compliance and the development of medical products. Through this collaborative approach and strategic expansion, he is poised to continue making meaningful contributions to the field while advancing the growth and success of his company.
For more information, please visit:
Contact Dr. Barker:
